Julian Caro‐Moreno

ORCID: 0000-0001-9709-7811
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Systemic Lupus Erythematosus Research
  • Biosimilars and Bioanalytical Methods
  • Biotechnology and Related Fields
  • Pharmaceutical Economics and Policy
  • Autoimmune and Inflammatory Disorders Research
  • Pharmaceutical studies and practices
  • Viral Infections and Immunology Research
  • Thyroid Disorders and Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes and associated disorders
  • Atherosclerosis and Cardiovascular Diseases
  • Systemic Sclerosis and Related Diseases
  • Rheumatoid Arthritis Research and Therapies

Universidad del Rosario
2013-2014

Summary Objectives To determine the prevalence and predictive factors of autoimmune hypothyroidism ( AH ) within a systemic lupus erythematosus SLE cohort to analyse current information concerning impact thyroid disease AITD autoimmunity in patients with . Methods A total 376 were assessed for presence following: (i) confirmed , (ii) positive thy‐roperoxidase/thyroglobulin antibodies [ TPOA b/TgAb] without hypothyroidism, (iii) nonautoimmune (iv) neither. Multivariate analysis classification...

10.1111/cen.12662 article EN Clinical Endocrinology 2014-11-08

Abstract: Biotherapeutic products have revolutionized medicine, changing the way we can treat some chronic diseases, such as autoimmune diseases. The patent expiry and high costs of reference biotherapeutic products, among other factors, promoted interest in similar (SBPs), also known biosimilars. objective developing an SBP is to manufacture a “highly similar” molecule product, by conducting comparability exercise that demonstrate quality, safety, efficacy. Regulations like those World...

10.2147/bs.s38572 article EN Biosimilars 2013-01-01

<h3>Objectives</h3> To analyze the influence of socioeconomic status (SES) on course autoimmune rheumatic diseases (AIRD) in an admixed and socio demographic heterogeneous population. <h3>Methods</h3> This was a cross-sectional analytical study which 1096 consecutive patients with rheumatoid arthritis (RA, n=678), systemic lupus erythematosus (SLE, n=258), Sjögren syndrome (SS, n=160) were included. SES categorized according to national legislation dichotomized as high (status 3 6) low 1...

10.1136/annrheumdis-2012-eular.1341 article EN Annals of the Rheumatic Diseases 2013-06-01
Coming Soon ...